UPDATE 2-EQT to buy molecular testing firm Qiagen for $10.8 billion

1

(Recasts throughout with details on deal, background, financials) Oct 21 (Reuters) – Sweden's EQT will buy molecular testing company Qiagen for about €9.6 billion ($10.78 billion), the companies said

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)